CY1120100T1 - Υδατοδιαλυτα υμενια τα οποια περιλαμβανουν αλγινικες ενωσεις χαμηλου ιξωδους - Google Patents

Υδατοδιαλυτα υμενια τα οποια περιλαμβανουν αλγινικες ενωσεις χαμηλου ιξωδους

Info

Publication number
CY1120100T1
CY1120100T1 CY20181100349T CY181100349T CY1120100T1 CY 1120100 T1 CY1120100 T1 CY 1120100T1 CY 20181100349 T CY20181100349 T CY 20181100349T CY 181100349 T CY181100349 T CY 181100349T CY 1120100 T1 CY1120100 T1 CY 1120100T1
Authority
CY
Cyprus
Prior art keywords
soluble
water
film
low visual
containing alginic
Prior art date
Application number
CY20181100349T
Other languages
English (en)
Inventor
Kjell Stenberg
Fredrik Hübinette
Original Assignee
Uppsalagruppen Medical Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uppsalagruppen Medical Ab filed Critical Uppsalagruppen Medical Ab
Publication of CY1120100T1 publication Critical patent/CY1120100T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007—Drug-containing films, membranes or sheets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465—Nicotine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
    • A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/02—Algae
    • A61K36/03—Phaeophycota or phaeophyta (brown algae), e.g. Fucus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Inorganic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Addiction (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Microbiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Psychiatry (AREA)
  • Mycology (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Jellies, Jams, And Syrups (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Manufacture Of Macromolecular Shaped Articles (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Materials For Medical Uses (AREA)

Abstract

Ένα υμένιο που περιλαμβάνει ως έναν παράγοντα σχηματισμού υμενίου ένα αλγινικό άλας μονοσθενούς κατιόντος ή ένα μίγμα αλγινικών αλάτων που περιέχει τουλάχιστον ένα αλγινικό άλας μονοσθενούς κατιόντος, όπου ο παράγοντας σχηματισμού υμενίου είναι τέτοιος ώστε ένα 10% υδατικό διάλυμα αυτού, σε θερμοκρασία 20°C να έχει ένα ιξώδες 100-1000 mPas, όπως μετράται με έναν ρυθμό διάτμησης 20 σαλ με τη χρήση ιξωδομέτρου Brookfield με μία άτρακτο αρ. 2. Μία μέθοδος παρασκευής του υμενίου. Το υμένιο είναι χρήσιμο για την χορήγηση δραστικών συστατικών σε ένα θηλαστικό.
CY20181100349T 2005-12-23 2018-03-27 Υδατοδιαλυτα υμενια τα οποια περιλαμβανουν αλγινικες ενωσεις χαμηλου ιξωδους CY1120100T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0502900A SE530184C2 (sv) 2005-12-23 2005-12-23 Bioadhesiv farmaceutisk filmkomposition innehållande lågviskösa alginater
PCT/SE2006/050626 WO2007073346A1 (en) 2005-12-23 2006-12-22 Water-soluble films comprising low-viscosity alginates

Publications (1)

Publication Number Publication Date
CY1120100T1 true CY1120100T1 (el) 2018-12-12

Family

ID=38188958

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20181100349T CY1120100T1 (el) 2005-12-23 2018-03-27 Υδατοδιαλυτα υμενια τα οποια περιλαμβανουν αλγινικες ενωσεις χαμηλου ιξωδους

Country Status (25)

Country Link
US (1) US8759282B2 (el)
EP (2) EP3335732B1 (el)
JP (1) JP5425471B2 (el)
KR (2) KR101484530B1 (el)
CN (1) CN101346154B (el)
AU (1) AU2006327277B2 (el)
BR (1) BRPI0620403B8 (el)
CA (1) CA2633878C (el)
CY (1) CY1120100T1 (el)
DK (1) DK1976562T3 (el)
ES (1) ES2664975T3 (el)
HR (1) HRP20180420T1 (el)
HU (1) HUE038619T2 (el)
IL (1) IL191994A (el)
LT (1) LT1976562T (el)
NO (1) NO343482B1 (el)
NZ (1) NZ569261A (el)
PL (1) PL1976562T3 (el)
PT (1) PT1976562T (el)
RS (1) RS57034B1 (el)
RU (1) RU2445977C2 (el)
SE (1) SE530184C2 (el)
SI (1) SI1976562T1 (el)
WO (1) WO2007073346A1 (el)
ZA (1) ZA200805287B (el)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL175338A0 (en) * 2006-05-01 2006-09-05 Biota Ltd Orally administrable films and preparation thereof
PT2405942T (pt) * 2009-03-13 2018-02-07 Excellent Tech Products I Sverige Ab Produto de administração oral
EP4342456A3 (en) * 2009-04-03 2024-06-05 British American Tobacco Sweden AB Plant fiber product and method for its manufacture
WO2012137610A1 (ja) * 2011-04-08 2012-10-11 国立大学法人山梨大学 医薬製剤
ITTO20120258A1 (it) * 2012-03-21 2013-09-22 Fond Istituto Italiano Di Tecnologia Materiali compositi polimerici con proprieta' antimicrobiche e biodegradabili e loro usi.
US10799451B2 (en) 2012-03-27 2020-10-13 Nicoccino Ab Nicotine formulation
SG11201405958RA (en) * 2012-03-27 2014-10-30 Nicoccino Ab Nicotine formulation
RU2525926C1 (ru) * 2013-01-09 2014-08-20 Мария Александровна Никулина Водорастворимая биодеградируемая съедобная упаковочная пленка
JP6001108B2 (ja) * 2015-02-02 2016-10-05 エクス−インターナショナル・エピエス 植物繊維製品およびその製造方法
CA3040014A1 (en) * 2016-11-15 2018-05-24 Klaria Pharma Holding Ab Pharmaceutical formulation
GB201709141D0 (en) * 2017-06-08 2017-07-26 Klaria Pharma Holding Ab Pharmaceutical formulation
MX2020005890A (es) 2017-12-20 2020-10-19 Klaria Pharma Holding Ab Formulacion de pelicula que comprende vardenafil, metodo para su preparacion y uso de la misma.
GB201807942D0 (en) * 2018-05-16 2018-06-27 Klaria Pharma Holding Ab Pharmaceutical formulation
GB201808462D0 (en) 2018-05-23 2018-07-11 Klaria Pharma Holding Ab Pharmaceutical formulation
CN108815141A (zh) * 2018-08-24 2018-11-16 中国农业科学院饲料研究所 抗菌肽膜剂及其制备方法与应用
CN113423290B (zh) * 2018-12-28 2023-08-04 菲利普莫里斯生产公司 包含金属盐的尼古丁制剂
US11877590B2 (en) 2019-03-27 2024-01-23 Fiedler & Lundgren Ab Smokeless tobacco composition
GB201911715D0 (en) * 2019-08-15 2019-10-02 Klaria Pharma Holding Ab Film formulation comprising carriers
EP4054523A1 (en) * 2019-11-04 2022-09-14 Maabarot Products Ltd. Orally administrable films comprising poorly water soluble active ingredients and preparation thereof

Family Cites Families (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4029757A (en) 1975-12-15 1977-06-14 Hoffmann-La Roche Inc. Manufacture of pharmaceutical unit dosage forms
US4029758A (en) 1975-12-15 1977-06-14 Hoffmann-La Roche Inc. Preparation of pharmaceutical unit dosage forms
US4031200A (en) 1975-12-15 1977-06-21 Hoffmann-La Roche Inc. Manufacture of pharmaceutical unit dosage forms
US4713239A (en) 1979-05-29 1987-12-15 Vsesojuny Kardiologichesky Nauchny Tsentr Adkaemii Meditsinski Nauk Sssr Antianginal film and method of treating ischemic heart disease
GB8301659D0 (en) 1983-01-21 1983-02-23 Leo Ab Smoking substitutes
US5783207A (en) 1985-05-01 1998-07-21 University Of Utah Research Foundation Selectively removable nicotine-containing dosage form for use in the transmucosal delivery of nicotine
US5229164A (en) 1985-12-19 1993-07-20 Capsoid Pharma Gmbh Process for producing individually dosed administration forms
JPH0729915B2 (ja) 1986-02-01 1995-04-05 帝國製薬株式会社 シ−ト状口腔内貼付剤
US4867970A (en) 1987-05-21 1989-09-19 E. R. Squibb & Sons, Inc. Moistureless oral drug delivery formulation and method for preparing same
US5446070A (en) 1991-02-27 1995-08-29 Nover Pharmaceuticals, Inc. Compositions and methods for topical administration of pharmaceutically active agents
US5656286A (en) 1988-03-04 1997-08-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
US4900552A (en) 1988-03-30 1990-02-13 Watson Laboratories, Inc. Mucoadhesive buccal dosage forms
US5047244A (en) 1988-06-03 1991-09-10 Watson Laboratories, Inc. Mucoadhesive carrier for delivery of therapeutical agent
JPH02258718A (ja) 1989-03-31 1990-10-19 Nippon Kayaku Co Ltd ペースト状基剤及び製剤
IT1248666B (it) 1990-05-30 1995-01-26 Fidia Spa Gel in forma di film autosupportanti altamente idrati, processo per laloro preparazione e impiego nella terapia di lesioni e/o patologie cutanee
GB9016056D0 (en) 1990-07-21 1990-09-05 Chatfield Pharmaceuticals Limi Transdermal medicine delivery devices
SE9003712L (sv) 1990-11-22 1992-01-07 Kabi Pharmacia Ab Gelbildande flytande baerarkomposition samt anvaendning daerav i farmaceutiska kompositioner
IT1250421B (it) 1991-05-30 1995-04-07 Recordati Chem Pharm Composizione farmaceutica a rilascio controllato con proprieta' bio-adesive.
US5215758A (en) 1991-09-11 1993-06-01 Euroceltique, S.A. Controlled release matrix suppository for pharmaceuticals
US5192802A (en) 1991-09-25 1993-03-09 Mcneil-Ppc, Inc. Bioadhesive pharmaceutical carrier
US5318780A (en) 1991-10-30 1994-06-07 Mediventures Inc. Medical uses of in situ formed gels
US5346701A (en) 1993-02-22 1994-09-13 Theratech, Inc. Transmucosal delivery of macromolecular drugs
US5700478A (en) 1993-08-19 1997-12-23 Cygnus, Inc. Water-soluble pressure-sensitive mucoadhesive and devices provided therewith for emplacement in a mucosa-lined body cavity
CN1131018C (zh) 1994-03-07 2003-12-17 瑟拉技术有限公司 含药物的粘着复合的透皮给药药贴及其制备方法
DE69510894T2 (de) 1994-06-16 2000-02-03 Pharmacia & Upjohn Spa Verfahren zur Herstellung mucoadhesiver Stärke
AU2703795A (en) 1994-06-23 1996-01-19 Procter & Gamble Company, The Treatment of nicotine craving and/or smoking withdrawal symptoms with a transdermal or transmucosal composition containing nicotine and caffeine or xanthine
GB9504599D0 (en) 1995-03-03 1995-04-26 Reckitt & Colmann Prod Ltd Improvements in or relating to organic compositions
GB2298365B (en) 1995-03-03 1997-05-07 Reckitt & Colmann Prod Ltd A liquid pharmaceutical composition alginate and potassium bicarbonate
DE19646392A1 (de) * 1996-11-11 1998-05-14 Lohmann Therapie Syst Lts Zubereitung zur Anwendung in der Mundhöhle mit einer an der Schleimhaut haftklebenden, Pharmazeutika oder Kosmetika zur dosierten Abgabe enthaltenden Schicht
NO983911D0 (no) 1998-08-26 1998-08-26 Norsk Hydro As Alginatkapsler til bruk ved behandling av hjernesvulst
GB0005743D0 (en) * 2000-03-10 2000-05-03 Reckitt & Colmann Prod Ltd Pharmaceutical compositions including alginates
US6932861B2 (en) * 2000-11-28 2005-08-23 Fmc Corporation Edible PGA coating composition
US6419903B1 (en) 2001-08-20 2002-07-16 Colgate Palmolive Company Breath freshening film
CA2473967C (en) 2001-10-12 2011-06-14 Monosolrx Llc Thin film with non-self-aggregating uniform heterogeneity, process for their production and drug delivery systems made therefrom
EP2332523B8 (en) 2001-10-12 2022-04-20 Aquestive Therapeutics, Inc. Uniform films for rapid dissolve dosage form incorporating taste-masking compositions
FR2832311B1 (fr) 2001-11-21 2004-04-16 Besins Int Belgique Poudre filmogene, compositions la comprenant, leurs procedes de preparation et leurs utilisations
GB2384986B (en) * 2002-02-12 2004-01-07 Reckitt Benckiser Healthcare Compositions for the treatment of disorders of the upper gastrointestinal tract
NO20021592D0 (no) 2002-04-04 2002-04-04 Fmc Biopolymer As Polysakkaridkapsler og fremgangsmåte ved fremstilling derav
GB0210216D0 (en) 2002-05-03 2002-06-12 First Water Ltd Ionically crosslinked alginate hydrogels, process for their manufacture and their use in medical devices
US20040131661A1 (en) 2002-07-26 2004-07-08 Pfizer Inc. Process for making orally consumable dosage forms
GB0217382D0 (en) 2002-07-26 2002-09-04 Pfizer Ltd Process for making orally consumable dosage forms
MXPA05004578A (es) 2002-10-31 2005-07-26 Umd Inc Composicion terapeutica para el suministro de drogas a y a traves de epitelios de proteccion.
US20040115137A1 (en) * 2002-12-17 2004-06-17 Verrall Andrew P. Water-soluble film for oral administration
WO2004067004A1 (en) * 2003-01-31 2004-08-12 Orexo Ab A rapid-acting pharmaceutical composition
GB2398496A (en) 2003-02-20 2004-08-25 Reckitt Benckiser Healthcare Suspensions of water-swellable polymer particles which are substantially water-free or contain insufficient water to fully swell the particles
US20050019294A1 (en) 2003-04-14 2005-01-27 Fmc Corporation Homogeneous, thermoreversible alginate films and soft capsules made therefrom
KR101128201B1 (ko) 2003-04-14 2012-03-23 에프엠씨 코포레이션 카파-2 카라기난을 함유하는 균질한 열가역성 젤 필름 및이로부터 제조된 연질 캡슐
US20050013847A1 (en) * 2003-04-14 2005-01-20 Fmc Corporation Delivery systems of homogeneous, thermoreversible alginate films
US7243881B2 (en) 2003-06-03 2007-07-17 The Boeing Company Multi-function trailing edge devices and associated methods
WO2005089722A1 (en) 2004-03-12 2005-09-29 Biodel, Inc. Rapid acting drug delivery compositions

Also Published As

Publication number Publication date
ZA200805287B (en) 2009-11-25
EP1976562A1 (en) 2008-10-08
BRPI0620403A2 (pt) 2012-12-11
JP5425471B2 (ja) 2014-02-26
LT1976562T (lt) 2018-05-25
AU2006327277B2 (en) 2012-12-13
BRPI0620403B8 (pt) 2021-05-25
PT1976562T (pt) 2018-04-09
SE530184C2 (sv) 2008-03-18
EP1976562A4 (en) 2012-02-01
SE0502900L (sv) 2007-06-24
BRPI0620403B1 (pt) 2020-11-10
RU2445977C2 (ru) 2012-03-27
RU2008130391A (ru) 2010-01-27
NZ569261A (en) 2012-08-31
NO20083226L (no) 2008-09-18
EP1976562B1 (en) 2018-02-21
CN101346154A (zh) 2009-01-14
SI1976562T1 (en) 2018-06-29
PL1976562T3 (pl) 2018-06-29
CA2633878C (en) 2015-02-10
CN101346154B (zh) 2013-03-27
IL191994A (en) 2013-09-30
KR20140046488A (ko) 2014-04-18
DK1976562T3 (en) 2018-04-16
US20090221489A1 (en) 2009-09-03
HRP20180420T1 (hr) 2018-06-01
JP2009521433A (ja) 2009-06-04
NO343482B1 (no) 2019-03-25
AU2006327277A1 (en) 2007-06-28
HUE038619T2 (hu) 2018-10-29
EP3335732B1 (en) 2020-10-14
KR101484530B1 (ko) 2015-01-20
CA2633878A1 (en) 2007-06-28
WO2007073346A1 (en) 2007-06-28
KR20080080405A (ko) 2008-09-03
RS57034B1 (sr) 2018-05-31
ES2664975T3 (es) 2018-04-24
US8759282B2 (en) 2014-06-24
IL191994A0 (en) 2008-12-29
EP3335732A1 (en) 2018-06-20

Similar Documents

Publication Publication Date Title
CY1120100T1 (el) Υδατοδιαλυτα υμενια τα οποια περιλαμβανουν αλγινικες ενωσεις χαμηλου ιξωδους
MX2020012041A (es) Formulacion farmaceutica.
CY1119812T1 (el) Διαδικασια για την παρασκευη μιας δικτυωτης γελης
CY1122252T1 (el) Ενεσιμο παρασκευασμα
AR067353A1 (es) Producto alimenticio funcional que contiene una mezcla de fibras especifica
BR112017018260A2 (pt) éteres de celulose esterificados solúveis água tendo um baixo grau de neutralização
BR112017018367A2 (pt) gelificação de éteres de celulose esterificados
BRPI0814957B8 (pt) composto, agente farmacêutico, e, uso do composto
BR112017007484A2 (pt) composições de polímero
DK1937891T3 (da) Fortykningsmiddel til farvesystemer
BR112015012972A2 (pt) método para tratar uma formação subterrânea, composição para tratamento de uma formação subterrânea, e, método para preparo de uma composição aquosa para tratamento de uma formação subterrânea
AR094936A1 (es) Suspensión para administración oral que comprende tolvaptán amorfo, y a un método para producirla
MX2021006790A (es) Formulacion de tableta para compuestos activos de peptido relacionado con el gen de calcitonina.
EA201891754A1 (ru) Композиции гиалуроновой кислоты, включающие мепивакаин
BR112015029911A2 (pt) bolo alimentar líquido coesivo compreendendo moléculas que fornecem viscoelasticidade
BR112018005463A2 (pt) composição aquosa compreendendo éter de celulose esterificado disperso
GB201020190D0 (en) Glucans
MX362918B (es) Película mucoadhesiva que contiene nicotina y método para su fabricación.
BR112015026913A2 (pt) processo para a obtenção de um gel estável de ácido hialurônico e de uma forma livre de vitamina c e/ou um sal respectivo
BR112019001841A2 (pt) composição para cuidados pessoais.
RU2483094C2 (ru) Жидкость-песконоситель для гидравлического разрыва пласта
BR112014018138B8 (pt) composição de tratamento de superfície, meio de impressão e método para preparar uma composição de tratamento de superfície utilizada na fabricação de papel
BR112015005605A2 (pt) musgo de turfa com capacidade de umedecimento, método de preparação, e método de utilização
CY1121570T1 (el) Σκευασμα νικοτινης
CL2017003464A1 (es) Composición estabilizadora de suelos que comprende azotobacter vinelandii, acidithiobacillus ferrooxidans, alginasa, y cloruro de calcio; método de estabilización de suelos; método de preparación de caminos estabilizados; uso de la composición estabilizadora de suelos.